Among these, triple agonists targeting GLP-1, GIP, and glucagon receptors represent a promising next step
View image online ( Patient holding injectable Use of GLP-1 receptor agonistswith or without glucose-dependent insulinotropic polypeptide (GIP)may be associated with improved clinical outcomes in patients with Type 1 diabetes, according to a large retrospective analysis published in Diabetes Technology & Therapeutics
Patients administer a weekly subcutaneous injection, typically in the abdomen, thigh, or upper arm
The pharmacology of drugs such as Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and dual incretin receptor agonists is mainly characterized by two mechanisms of action
For Wegovy and Ozempic (weekly injections): If you miss a dose and its been less than 5 days since your missed dose, take it as soon as you remember
These medicines are transforming obesity treatment and can achieve important weight loss